前线转移性膀癌的未来是没有的
1Barts Cancer Institute, Queen Mary University of London, London, UK.
European urology focus
|April 24, 2024
概括
恩福图马布 (Enfortumab vedotin) 加上潘布罗利祖马布 ( pembrolizumab) 现在是转移性膀癌的标准治疗方法,比化疗更能改善存活率. 这种组合疗法在患者护理中带来了新的机遇和挑战.
科学领域:
- 在瘤学瘤学.
- 医疗 治疗 医疗 治疗
背景情况:
- 从历史上看,转移性膀癌的治疗一直很困难.
- 以为基础的化疗是以前的标准治疗方法.
研究的目的:
- 讨论在转移性膀癌中使用enfortumab vedotin加上 pembrolizumab (EV/P) 的益处.
- 探索不断变化的治疗环境中新出现的问题.
主要方法:
- 文献审查和临床数据分析.
- 讨论最近在膀癌治疗方面的进展.
主要成果:
- 恩福图马布维多丁加上潘布罗利祖马布 (EV/P) 显示了改善的生存率和反应率.
- EV/P正在取代基于的化疗,成为新的护理标准.
结论:
- EV/P代表了转移性膀癌治疗的重大进展.
- 需要进一步的研究来解决这个新的治疗方法所产生的问题.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K